There is an increasing trend of intentionally or unintentionally using non-insulin-based treatment for managing T2DM during pregnancy, with a progressive interest towards glucagon-like peptide-1 receptor agonists (GLP-1RA) in this context.4 Here, INS is linked to type 2 diabetes mellitus.